Market

COHANCE LIFESCIENCES LTD.

  • NSE CodeCOHANCEEQ
  • BSE Code543064
  • ISININE03QK01018
  • IndustryPharmaceuticals


Company Information

Management

Mr. K Hanumantha Rao

Co. Secretary & Compl. Officer

Mr. Himanshu Agarwal

Chief Financial Officer

Dr. Sudhir Kumar Singh

Chief Executive Officer

Mr. Gaurav Bahadur

Chief Human Resource Officer

Incorporation Year

06/11/2018

Registered Address

Registered Office : 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala MIDC,
Mumbai, Maharashtra - 400093
Tel: 022-61539999, 23549414, 23541142
Fax: 022-23541152

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

info@suvenpharm.com

Website

www.suvenpharm.com

Listing

BSE, BSE, NSE

Corporate News

Cohance Lifesciences - Compliances-Certificate under ...

02-Jul-2025|7:35PM

Compliance Certificate Under Regulation 74(5) of SEBI (DP) Regulations 2018

Cohance Lifesciences - Certificate under SEBI (Deposi...

02-Jul-2025|7:33PM

Cohance Lifesciences Limited has informed the Exchange about Certificate un

Cohance Lifesciences - Board Meeting Intimation

27-Jun-2025|7:19PM

Cohance Lifesciences Limited has informed the Exchange about Board Meeting

Cohance Lifesciences - Trading Window-XBRL

27-Jun-2025|6:42PM

Cohance Lifesciences Limited has informed the Exchange about Closure of Tra

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug72.42205.34
Aarti Drug487.454,448.96
Aarti Pharma900.358,160.29
Abbott India34,735.0073,809.45
Accent Micro269.70646.98

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
DSP Healthcar..260.838.81
DSP ELSS Tax ..200.121.18
Invesco India..199.801.09
DSP Flexi Cap..191.791.62
UTI Flexi Cap..189.740.75

Board Meetings

DatePurpose
13/08/2025Quarterly Results
28/05/2025Audited Results
12/02/2025Quarterly Results
12/11/2024Quarterly Results
09/08/2024Quarterly Results